Clinical Trials Browser

Recruiting × INDUSTRY × regorafenib × Clear all

NCT06047379 2026-03-02

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Astrocytoma, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Central Nervous System Neoplasms, Small Cell Lung Carcinoma

NCT07310173 2025-12-30

Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma

Phase 2 Recruiting

75 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04701476 2024-11-22

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Phase 2 Recruiting

110 enrolled

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms